ArticleInternational journal of clinical and experimental pathology2015

Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.

Jiang-Ying Ru et al.PubMed ↗Full text ↗

No numbers read from the abstract.